Resources

Leading the Way in Effective Drug Development

Posters

Assessing the Value of an AI Platform During Screening to Predict Adherence to Study Drug During Treatment in an Ongoing Proof-of-concept Study in Schizophrenia

Posters

Using Artificial Intelligence Platforms to Enhance Study Design in Schizophrenia Trials

Posters

Using Artificial Intelligence Platforms to Monitor and Identify Early Nonadherence Activity Based on Visual Confirmation of Medication Ingestion

Posters

Evaluating the Use of an Artificial Intelligence (AI) Platform on Mobile Devices to Measure and Support Tuberculosis Medication Adherence

Posters

Evaluating the Use of an Artificial Intelligence Platform on Mobile Devices to Measure Adherence in Subjects With an Acute Exacerbation of Schizophrenia

Posters

Facial and Vocal Markers of Schizophrenia Measured Using Remote Smartphone Assessments

Posters

Smartphone-based Artificial Intelligence Platform Demonstrates High Rates of Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir

Posters

Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy

Posters

Using Artificial Intelligence on Mobile Devices to Measure and Maximize Medication Adherence in CNS Trials